Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Baldwin

Showing results (41-50 of 1,173) with videos related to

Pageof 118
Sort By:
International Journal of Psychiatry in Clinical Practice|June 13, 2014
Serotonin noradrenaline reuptake inhibitors: A new generation of treatment for anxiety disordersDavid S Baldwin
Human Psychopharmacology|October 12, 2012
Where is the room for improvement in the drug treatment of depression and anxiety?David S Baldwin
The British Journal of Psychiatry : the Journal of Mental Science|May 28, 2026
<i>Antidepressants</i> by Suede: songs of fear, unease and worry - Psychiatry in musicDavid S Baldwin
Hospital Medicine (London, England : 1998)|December 12, 2002
Escitalopram: efficacy and tolerability in the treatment of depressionDavid S Baldwin
Human Psychopharmacology|December 26, 2024
Nick Drake: A Troubled Mind, a Troublesome 'Cure'David S Baldwin
Human Psychopharmacology|October 31, 2002
Unmet needs in the pharmacological management of depressionDavid S. Baldwin
The American Journal of Medicine|January 1, 1977
Poststreptococcal glomerulonephritis. A progressive disease?D S Baldwin
Human Psychopharmacology|December 8, 2022
'Nico'-A lone voyager in Strange SeasDavid S Baldwin
Biochemical Pharmacology|April 13, 2001
Inhibition of the preferential binding of actin to the N-terminal hydratase domain of the 78-kDa gastrin-binding protein by non-steroidal anti-inflammatory drugs and gastrin receptor antagonistsG S Baldwin
The Journal of Clinical Investigation|January 3, 2001
Series introduction: the transcription factor NF-kappaB and human diseaseA S Baldwin
Pageof 118

Showing results (41-50 of 1,173) with videos related to

Sort By:
Pageof 118
International Journal of Psychiatry in Clinical Practice|June 13, 2014
Serotonin noradrenaline reuptake inhibitors: A new generation of treatment for anxiety disordersDavid S Baldwin
Human Psychopharmacology|October 12, 2012
Where is the room for improvement in the drug treatment of depression and anxiety?David S Baldwin
The British Journal of Psychiatry : the Journal of Mental Science|May 28, 2026
<i>Antidepressants</i> by Suede: songs of fear, unease and worry - Psychiatry in musicDavid S Baldwin
Hospital Medicine (London, England : 1998)|December 12, 2002
Escitalopram: efficacy and tolerability in the treatment of depressionDavid S Baldwin
Human Psychopharmacology|December 26, 2024
Nick Drake: A Troubled Mind, a Troublesome 'Cure'David S Baldwin
Human Psychopharmacology|October 31, 2002
Unmet needs in the pharmacological management of depressionDavid S. Baldwin
The American Journal of Medicine|January 1, 1977
Poststreptococcal glomerulonephritis. A progressive disease?D S Baldwin
Human Psychopharmacology|December 8, 2022
'Nico'-A lone voyager in Strange SeasDavid S Baldwin
Biochemical Pharmacology|April 13, 2001
Inhibition of the preferential binding of actin to the N-terminal hydratase domain of the 78-kDa gastrin-binding protein by non-steroidal anti-inflammatory drugs and gastrin receptor antagonistsG S Baldwin
The Journal of Clinical Investigation|January 3, 2001
Series introduction: the transcription factor NF-kappaB and human diseaseA S Baldwin
Pageof 118